Concepedia

Marc Fenster

MF

Statistics

Publications

8

Citations

289

H-Index

8

Active since

2018

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Washington University in St. Louis

Brooke Army Medical Center

Cedars-Sinai Medical Center

Montefiore Medical Center

Marc Fenster is an author at Icahn School of Medicine at Mount Sinai specializing in inflammatory bowel disease therapy, gastrointestinal inflammation, and pharmacotherapy.

Publications per year

2018–2025

8

Publications

8

Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis

Parakkal Deepak, Quazim A. Alayo, Aava Khatiwada et al. · Clinical Gastroenterology and Hepatology · 2020 · 107 citations · Full text

, , +11

Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease

Quazim A. Alayo, Marc Fenster, Osama Altayar et al. · Crohn s & Colitis 360 · 2022 · 79 citations · Full text

, , +14

Real-World Effectiveness and Safety of Tofacitinib in Crohn’s Disease and IBD-U: A Multicenter Study From the TROPIC Consortium

Marc Fenster, Quazim A. Alayo, Aava Khatiwada et al. · Clinical Gastroenterology and Hepatology · 2020 · 37 citations · Full text

, , +13

Real‐world multicentre experience of the pathological features of colonic ischaemia and their relationship to symptom duration, disease distribution and clinical outcome

Marc Fenster, Paul Feuerstadt, Lawrence J. Brandt et al. · Colorectal Disease · 2018 · 16 citations

, , +15

P344 Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study

Ryan C. Ungaro, Marc Fenster, Christina Dimopoulos et al. · Journal of Crohn s and Colitis · 2019 · 16 citations · Full text

, , +13

1–5 of 8